Authors
Professor of Clinical Neurology, University of Rochester Medical Center
Associate Professor; Director of Outpatient Operations, Jefferson Headache Center; Co-Chief, Division of Headache, Jefferson University Hospital
Aging Incubator, New York University, in New York, New York
Director of Regulatory Affairs at the National MS Society.
Program Director, Multiple Sclerosis Fellowship; Neurologist, The Ohio State Neurological Institute
Speech-Language Pathologist, Brooks Rehabilitation Outpatient Clinic – Orange Park.
Senior editor, Practical Cardiology and Endocrinology Network
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Real-World Survey Data Suggest Deutetrabenazine May Improve Quality of Life Measures in Huntington Disease Chorea
2
Earlier Pimavanserin Initiation May Alter Psychosis Symptom Trajectory in Parkinson's Disease, Exploratory Analysis Suggests
3
Discontinuing Disease-Modifying Therapy in Older Patients With MS: John Corboy, MD
4
Anti-PACAP Antibody Bocunebart Meets Primary Endpoint in Phase 2b Migraine Prevention Trial
5
